References
- Cox K, McGarry J. Why patients don’t take part in cancer clinical trials: an overview of the literature. Eur J Cancer Care. 2003; 12(2):114–122.
- Somkin CP, Altschuler A, Ackerson L, et al. Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care. 2005;11(7):413–421.
- Comis RL, Miller JD, Colaizzi DD, et al. Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract. 2009;5(2):50–56.
- Long DG. Clinical trials. A family physician’s perspective. Cancer. 1991;67(S6):1798–1799.
- Dolor RJ, Schmit KM, Graham DG, et al. Guidance for researchers developing and conducting clinical trials in practice-based research networks (PBRNs). J Am Board Fam Med. 2014;27(6):750–758.
- Taylor H. Public awareness of clinical trials increases: new survey suggests those conducting trials are doing a better job of informing potential participant of opportunities. Harris Interact Healthc News. 2004;4:1–9.
- IOM (Institute of Medicine). A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC: The National Academies Press; 2010.
- Association of Clinical Research Professionals (ACRP). CenterWatch 2008 national survey of study volunteer experiences. Paper presented at the ACRP 2009 Global Conference and Exhibition; April 24-28; 2009; Denver, CO.
- Pretesting NIH clinical trial awareness messages: a focus study with patients, caregivers, and the general public. Bethesda, MD: National Institutes of Health; 2011.
- Joshi VD, Oka GA, Kulkarni AA, et al. Public awareness and perception of clinical trials: quantitative study in Pune. Perspect Clin Res. 2013;4(3):169–174.
- Schain WS. Barriers to clinical trials. Part II: knowledge and attitudes of potential participants. Cancer. 1994;74(Suppl 9):2666–2671.
- European Commission. Enterprise and industry directorate-general. Detailed guidelines on good clinical practice specific to advanced therapy medicinal products. Consumer goods. ENTR/F/2/SF/dn D(2009) 35810. Brussels: Pharmaceuticals; 2009.
- De Pablo López de Abechuco I, Gálvez-Múgica M, Aguilar-Jiménez M, et al. Compresión del consentimiento informado de ensayos clínicos: encuesta a pacientes y a voluntarios. Conference and abstracts book. ANCEI Congress; 2015:121–125; Zaragoza, Spain.
- Solanilla M, Rumi L, Zapata A, et al. “Nivel de información recibido y comprendido en pacientes que participan en ensayos clínicos oncológicos”. Conference and abstracts book. ANCEI Congress; 2014:99–100; Madrid, Spain.
- ECMC Research Nurse Network Group Steering Committee. Promoting patient safety in cancer clinical trials. UKONS Oncology Nursing Society Newsletter. Issue 28; 2014. Available from:http://ukons.org/newsletters. Accessed March 15, 2017.